Profile
| Metric | Value |
|---|---|
| Full Name | Blueprint Medicines Corporation |
| Ticker | NASDAQ: BPMC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | blueprintmedicines.com |
| Employees | 682 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| N/A | - | |
| $509M | ||
| Revenue, 1Y Change | +104.04% | |
| -$1.07 | ||
| EPS, 1Y Change | +87.25% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.07 | ||
| EPS Estimate | N/A | -$0.71 |
| EPS Est. Change | N/A | +33.33% |
| $508.82M | ||
| Revenue Estimate | N/A | $723.30M |
| Revenue Est. Change | N/A | +42.15% |
| Current Price | - | |
| Price Target | - | $129.00 |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$8.58 | -$8.37 | +2.43% | |
| -$1.37 | -$1.07 | +22.04% | |
| -$0.71 | N/A | +33.33% | |
| $1.15 | N/A | +207.75% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $244.80M | $249.38M | +1.87% | |
| $507.90M | $508.82M | +0.18% | |
| $723.30M | N/A | +42.15% | |
| $1.02B | N/A | +99.50% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | - | |
| N/A | - | |
| SMA 200 vs Price | N/A | - |
| N/A | - | |
| SMA 50 vs Price | N/A | - |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $508.82M | ||
| -$1.07 | ||
| $472.37M | ||
| 92.84% | ||
| -$212.04M | ||
| -41.67% | ||
| -$67.09M | ||
| -13.19% | ||
| $19.23M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 2.43 | ||
| 2.85 | ||
| 2.80 | ||
| - | ||
| 3 | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $298.67M | ||
| $102.01M | ||
| $1.18B | ||
| $742.68M | ||
| $881.15M | ||
| $260.80M | ||
| $724.28M | ||
| $57.26M | ||
| $6.79M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $720.87M | ||
| $700.71M | ||
| $36.45M | ||
| $359.27M | ||
| $16.29M | ||
| $0.00 | ||
| $1.23M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$192.59M | ||
| -$47.50M | ||
| $273.11M | ||
| $4.63M | ||
| -$197.22M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| UBS | → | |
| Morgan Stanley | → | |
| Citigroup | → | |
| Wolfe Research | → | |
| JMP Securities | → | |
| Wedbush | → | |
| Scotiabank | → | |
| Needham | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with BPMC
FAQ
What is the ticker symbol for Blueprint Medicines Corporation?
The ticker symbol for Blueprint Medicines Corporation is NASDAQ:BPMC
Does Blueprint Medicines Corporation pay dividends?
No, Blueprint Medicines Corporation does not pay dividends
What sector is Blueprint Medicines Corporation in?
Blueprint Medicines Corporation is in the Healthcare sector
What industry is Blueprint Medicines Corporation in?
Blueprint Medicines Corporation is in the Biotechnology industry
What country is Blueprint Medicines Corporation based in?
Blueprint Medicines Corporation is headquartered in United States
When did Blueprint Medicines Corporation go public?
Blueprint Medicines Corporation initial public offering (IPO) was on April 30, 2015
Is Blueprint Medicines Corporation in the S&P 500?
No, Blueprint Medicines Corporation is not included in the S&P 500 index
Is Blueprint Medicines Corporation in the NASDAQ 100?
No, Blueprint Medicines Corporation is not included in the NASDAQ 100 index
Is Blueprint Medicines Corporation in the Dow Jones?
No, Blueprint Medicines Corporation is not included in the Dow Jones index
When was Blueprint Medicines Corporation last earnings report?
Blueprint Medicines Corporation's most recent earnings report was on July 31, 2025
When does Blueprint Medicines Corporation report earnings?
The date for Blueprint Medicines Corporation's next earnings report has not been announced yet
Data Sources & References
- BPMC Official Website www.blueprintmedicines.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1597264/000155837025006108/0001558370-25-006108-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1597264/000155837025000953/0001558370-25-000953-index.htm
- BPMC Profile on Yahoo Finance finance.yahoo.com/quote/BPMC
- BPMC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bpmc